These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 2246823)

  • 21. Fractionated total-body irradiation, etoposide, and cyclophosphamide followed by allogeneic bone marrow transplantation for patients with high-risk or advanced-stage hematological malignancies.
    Long GD; Amylon MD; Stockerl-Goldstein KE; Negrin RS; Chao NJ; Hu WW; Nademanee AP; Snyder DS; Hoppe RT; Vora N; Wong R; Niland J; Reichardt VL; Forman SJ; Blume KG
    Biol Blood Marrow Transplant; 1997 Dec; 3(6):324-30. PubMed ID: 9502300
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A study of thiotepa, etoposide and fractionated total body irradiation as a preparative regimen prior to bone marrow transplantation for poor prognosis patients with neuroblastoma.
    Kamani N; August CS; Bunin N; Leahey A; Bayever E; Goldwein J; Zusman J; Evans AE; Angio GD
    Bone Marrow Transplant; 1996 Jun; 17(6):911-6. PubMed ID: 8807093
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcome of second bone marrow transplantation following a uniform conditioning regimen as therapy for malignant relapse.
    Chiang KY; Weisdorf DJ; Davies SM; Enright H; Kersey JH; McGlave PB; Miller W; Ramsay NK; Steinbuch M; Wagner JE; Blazar BR
    Bone Marrow Transplant; 1996 Jan; 17(1):39-42. PubMed ID: 8673052
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bone marrow transplantation for Fanconi's anaemia: the Hammersmith experience 1977-89.
    Hows JM; Chapple M; Marsh JC; Durrant S; Yin JL; Swirsky D; Gordon-Smith EC
    Bone Marrow Transplant; 1989 Nov; 4(6):629-34. PubMed ID: 2684308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sixteen adult patients with acute leukemia treated by chemotherapy, total body irradiation and allogeneic marrow transplantation.
    Kodera Y; Morishima Y; Morishita Y; Murase T; Okumura M; Yamada H; Minami S; Kato Y; Ogura M; Nagura E
    Jpn J Clin Oncol; 1984 Dec; 14 Suppl 1():479-85. PubMed ID: 6394811
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unrelated donor bone marrow transplantation for children with severe aplastic anemia: minimal GVHD and durable engraftment with partial T cell depletion.
    Bunin N; Aplenc R; Iannone R; Leahey A; Grupp S; Monos D; Pierson G
    Bone Marrow Transplant; 2005 Feb; 35(4):369-73. PubMed ID: 15640818
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bone marrow transplantation in children with severe aplastic anemia using a conditioning regimen containing 3 Gy of total body irradiation, cyclophosphamide with or without antithymocyte globulin.
    Inagaki J; Nagatoshi Y; Kawano Y; Saito Y; Takahashi D; Nagayama J; Shinkoda Y; Hirata H; Okamura J
    Pediatr Transplant; 2007 Mar; 11(2):180-6. PubMed ID: 17300498
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Survival after ABO-incompatible allogeneic bone marrow transplant after a preparative regimen of busulfan and cyclophosphamide.
    Kalaycioglu M; Copelan E; Avalos B; Klein J; Goormastic M; Bolwell B
    Bone Marrow Transplant; 1995 Jan; 15(1):105-10. PubMed ID: 7742742
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unrelated donor bone marrow transplantation for Fanconi anemia.
    Davies SM; Khan S; Wagner JE; Arthur DC; Auerbach AD; Ramsay NK; Weisdorf DJ
    Bone Marrow Transplant; 1996 Jan; 17(1):43-7. PubMed ID: 8673053
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bone marrow transplantation from unrelated donors for patients with adult T-cell leukaemia/lymphoma.
    Nakase K; Hara M; Kozuka T; Tanimoto K; Nawa Y
    Bone Marrow Transplant; 2006 Jan; 37(1):41-4. PubMed ID: 16247419
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of conditioning regimen on the outcome of bone marrow transplantation from an unrelated donor.
    Kanda Y; Sakamaki H; Sao H; Okamoto S; Kodera Y; Tanosaki R; Kasai M; Hiraoka A; Takahashi S; Miyawaki S; Kawase T; Morishima Y; Kato S;
    Biol Blood Marrow Transplant; 2005 Nov; 11(11):881-9. PubMed ID: 16275591
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Successful allogeneic bone marrow transplantation in a case with myelodysplastic syndrome which developed following Fanconi anemia.
    Ikushima S; Hibi S; Todo S; Sawada T; Matsumoto Y; Iwami H; Tsunamoto K; Kasubuchi Y; Yabe M; Kato S
    Bone Marrow Transplant; 1995 Oct; 16(4):621-4. PubMed ID: 8528182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unrelated donor bone marrow transplantation in Fanconi anaemia: the Leiden experience.
    Zwaan CM; Van Weel-Sipman MH; Fibbe WE; Oudshoorn M; Vossen JM
    Bone Marrow Transplant; 1998 Mar; 21(5):447-53. PubMed ID: 9535036
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Experience using bone marrow transplantation in the treatment of hematologic neoplasms and solid tumors].
    Niederwieser D; Aulitzky W; Frommhold H; Schönitzer D; Url M; Allerberger F; Wiegele J; Gratwohl A; Braunsteiner H; Huber C
    Wien Klin Wochenschr; 1987 Jan; 99(2):49-53. PubMed ID: 3551339
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autologous hemopoietic reconstitution after fetal liver infusion in patients with bone marrow failure: consequence or coincidence?
    Sierra J; Badell I; Grañena A; García J; Marín P; Valls A; Carreras E; Torras A; Rovira M; Pujol E
    Bone Marrow Transplant; 1992 Apr; 9(4):235-9. PubMed ID: 1600411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bone marrow transplantation for myelodysplastic syndromes.
    Bélanger R; Gyger M; Perreault C; Bonny Y; St-Louis J
    Br J Haematol; 1988 May; 69(1):29-33. PubMed ID: 3289604
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bone marrow transplantation for myelodysplastic and myeloproliferative syndromes.
    O'Donnell MR; Nademanee AP; Snyder DS; Schmidt GM; Parker PM; Bierman PJ; Fahey JL; Stein AS; Krance RA; Stock AD
    J Clin Oncol; 1987 Nov; 5(11):1822-6. PubMed ID: 3316515
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Allogeneic bone marrow transplantation in patients with myelodysplastic syndromes.
    Uberti JP; Ratanatharathorn V; Karanes C; Sensenbrenner LL
    Leuk Lymphoma; 1994 Aug; 14(5-6):379-85. PubMed ID: 7812196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonmyeloablative allogeneic bone marrow transplantation for treatment of myelodysplastic syndrome complicated by recent intracerebral hemorrhage.
    Ohtsubo K; Takase K; Nagafuji K; Henzan H; Tanimoto T; Fukuda T; Miyamoto T; Inaba S; Harada M
    Am J Hematol; 2004 Dec; 77(4):400-4. PubMed ID: 15558806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.